Allergy or contraindication to paracetamol, Prasugrel or Ticagrelor
Paracetamol ingestion in the previous 48 hours
Patient treated with drugs supposed to alter gastric emptying times (calcium antagonists, Alimentary tract treatments, opioid analgesics, tricyclic antidepressants, antibiotics).
Conditions or pathologies supposed to alter gastric emptying times (Thyroid dysfunction, chronic renal failure, Parkinson's disease, scleroderma, amyloidosis, any gastrointestinal disease, any not cured malignancy, and any advanced psychiatric or neurological disease).
Presence of vomiting
Cardiogenic shock, ventricular arrhythmia or resuscitated cardiac arrest
Hepatic insufficiency
Severe respiratory disease
Pregnant or breastfeeding women

NCT02251249_exc_T1
Condition
Allergy
NCT02251249_exc_T2
Condition
contraindication
NCT02251249_exc_T3
Drug
paracetamol
NCT02251249_exc_T4
Drug
Prasugrel
NCT02251249_exc_T5
Drug
Ticagrelor
NCT02251249_exc_T6
Scope
paracetamol, Prasugrel or Ticagrelor
NCT02251249_exc_T7
Scope
Allergy or contraindication
NCT02251249_exc_T8
Drug
Paracetamol
NCT02251249_exc_T9
Temporal
in the previous 48 hours
NCT02251249_exc_T10
Drug
calcium antagonists
NCT02251249_exc_T11
Procedure
Alimentary tract treatments
NCT02251249_exc_T12
Drug
opioid analgesics
NCT02251249_exc_T13
Drug
tricyclic antidepressants
NCT02251249_exc_T14
Drug
antibiotics
NCT02251249_exc_T15
Condition
Thyroid dysfunction
NCT02251249_exc_T16
Condition
chronic renal failure
NCT02251249_exc_T17
Condition
Parkinson's disease
NCT02251249_exc_T18
Condition
scleroderma
NCT02251249_exc_T19
Condition
amyloidosis
NCT02251249_exc_T20
Condition
gastrointestinal disease
NCT02251249_exc_T21
Condition
malignancy
NCT02251249_exc_T22
Condition
chiatric or ease).
NCT02251249_exc_T23
Condition
neurological disease
NCT02251249_exc_T24
Qualifier
advanced
NCT02251249_exc_T25
Scope
psychiatric or neurological disease
NCT02251249_exc_T26
Condition
vomiting
NCT02251249_exc_T27
Condition
Cardiogenic shock
NCT02251249_exc_T28
Condition
ventricular arrhythmia
NCT02251249_exc_T29
Condition
cardiac arrest
NCT02251249_exc_T30
Qualifier
resuscitated
NCT02251249_exc_T31
Condition
Hepatic insufficiency
NCT02251249_exc_T32
Condition
respiratory disease
NCT02251249_exc_T33
Qualifier
Severe
NCT02251249_exc_T35
Drug
drugs supposed to alter gastric emptying times
NCT02251249_exc_T36
Scope
calcium antagonists, Alimentary tract treatments, opioid analgesics, tricyclic antidepressants, antibiotics
NCT02251249_exc_T37
Condition
pathologies supposed to alter gastric emptying times
NCT02251249_exc_T38
Condition
ditions or posed to alter gastric emptying times (T
NCT02251249_exc_T39
Scope
Conditions or pathologies supposed to alter gastric emptying times
NCT02251249_exc_T40
Scope
Thyroid dysfunction, chronic renal failure, Parkinson's disease, scleroderma, amyloidosis, any gastrointestinal disease, any not cured malignancy, and any advanced psychiatric or neurological disease
NCT02251249_exc_T34
Condition
Pregnant
NCT02251249_exc_T41
Observation
breastfeeding
NCT02251249_exc_T42
Person
women